VIDEO: Collagenase injection effective in Dupuytren’s disease with varied severity
In this video from the American Society for Surgery of the Hand Annual Meeting, Gary M. Pess, MD, FACS, FAAOS, discusses a Delphi method to assess collagenase clostridium histolyticum use among hand surgeons who treat Dupuytren’s disease.
Researchers used online surveys to determine whether consensus could be reached among 20 hand surgeons with expertise in Dupuytren’s disease (DD) regarding XIAFLEX (Endo International) collagenase clostridium histolyticum as a nonsurgical option for DD. They captured the responses using a five-point Likert scale.
“To my surprise and most of the panelists, we found that people were using XIAFLEX for a variety of contractures, including severe contractures of the [metacarpal] MP and [proximal interphalangeal] PIP joint, even patients with very limited skin and PIP joint capsular contractures,” Pess told Healio Orthopedics.